Versuchen GOLD - Frei
Big Oil's plastic conspiracy
Business Standard
|March 09, 2026
Last year, researchers at the University of New Mexico studying brain samples from two dozen people who died in 2024 estimated that each person’s brain contained around seven grams of plastic — an entire disposable spoon’s worth.
Those who suffered from dementia had more plastic in their brains than those who did not. That's correlation, not causation, and it will be years before scientists understand the health consequences of these synthetic particles in our tissue, but it is worrying all the same. When the researchers compared the 2024 brains with those of people who had died eight years earlier, the more recently deceased contained nearly 50 percent more plastic.
The study encapsulates the whole story of our planet awash in the stuff: Plastic has seeped into the most intimate recesses of our bodies, is implicated in a range of horrifying health outcomes and is rapidly accumulating in our environment in ever larger amounts. How did we get here — to the spoon in our brains?
Beth Gardiner’s rigorous new book, Plastic Inc., answers by way of a compelling true-crime story: Plastic took over the globe through decades of intensive marketing, political manoeuvring and flat-out deceit. Originally, plastic was a way for oil and gas companies to wring value out of petroleum. Today, Gardiner argues, oil and gas makers see plastic as a safeguard against falling revenue in a world reckoning with the climate consequences of burning its products, and aim to increase production significantly.
Diese Geschichte stammt aus der March 09, 2026-Ausgabe von Business Standard.
Abonnieren Sie Magzter GOLD, um auf Tausende kuratierter Premium-Geschichten und über 9.000 Zeitschriften und Zeitungen zuzugreifen.
Sie sind bereits Abonnent? Anmelden
WEITERE GESCHICHTEN VON Business Standard
Business Standard
Nalco urges Odisha govt to expedite land handover process for ‘30K cr projects
Navratna central public-sector enterprise (CPSE) Nalco has requested the Odisha government to expedite the land handover process for its 30,000 crore expansion projects that will boost capacity and help it achieve the Maharatna status by 2030.
1 mins
March 10, 2026
Business Standard
Women-led startups saw 9% funding drop in 2025
Female labour participation just 42%, among lowest in G20: Axis Bank study
3 mins
March 10, 2026
Business Standard
How India can kick the West Asian oil habit
Increasing the use of alternative fuels like ethanol could be one way out
6 mins
March 10, 2026
Business Standard
India’s T20 WC win brings new stars to brand crease
\"Sachin Tendulkar carried Indian cricket on his shoulders for 21 years.
3 mins
March 10, 2026
Business Standard
UBS downgrades OMCs as oil crosses $100/bbl
The recent rally in crude prices and refining margins create a sense of déjà vu, UBS said, mirroring the 2022 oil market disruption.
1 min
March 10, 2026
Business Standard
LIC drove 18% rise in life insurers’ NBP in Feb
New business premium of life insurance companies grew 18 per cent year-on-year (Y-o-Y) to ₹35,417 crore in February, driven by robust growth at the state-owned Life Insurance Corporation of India (LIC) due to a favourable base.
1 mins
March 10, 2026
Business Standard
Why India needs Russian oil
India's oil security is becoming increasingly fragile. Over 80 per cent of its crude imports come from just two suppliers — West Asia and Russia — both now facing geopolitical stress. In this environment, resuming full purchases of Russian oil may not be a choice but a necessity. Here are eight reasons why.
3 mins
March 10, 2026
Business Standard
India, Uzbekistan launch pharma-nutra corridor
India and Uzbekistan on Monday launched a structured pharmaceutical and nutraceutical trade corridor aimed at expanding access to the Commonwealth of Independent States (CIS) and the wider Eurasian healthcare market, estimated at $7-10 billion.
1 min
March 10, 2026
Business Standard
A clear derating
Markets risk underperformance if we don’t regain our growth credentials
5 mins
March 10, 2026
Business Standard
Delhi HC allows Dr Reddy’s to make semaglutide for export
A division Bench of the Delhi High Court on Monday affirmed a single-judge Bench’s order allowing pharmaceutical company Dr Reddy’s Laboratories to manufacture the diabetes and weight-management drug semaglutide in India for export to jurisdictions where Danish drugmaker Novo Nordisk does not have patent protection.
2 mins
March 10, 2026
Listen
Translate
Change font size
